Dose-Dense Sequential Adriamycin-Paclitaxel-Cyclophosphamide Chemotherapy Is Well Tolerated and Safe in High-Risk Early Breast Cancer
2005
Objective: The feasibility of dose-dense sequential adjuvant chemotherapy with Adriamycin, paclitaxel and cyclophosphamide was evaluated. Methods: Fifty-five high
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
7
Citations
NaN
KQI